Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products. Our divisions - Innovative Medicines (Pharma and Oncology), Alcon and Sandoz - are supported by functional organizations with global scale.
In Egypt, Novartis has been present for more than 52 years. Novartis Technical Operations, Cairo site manufactures for Pharma, Sandoz locally and provides additional capacity within Novartis’ global manufacturing and supply network (export business) . The manufacturing plant is situated in Al-Amiria District, Cairo. Total site size is 80’000 Sq m including all the necessary infrastructure.
To report an adverse event or any drug related issues concerning Novartis medicianal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event. Fax: 002 02 26031702. E-mail: [email protected]